Illumina DRAGEN Bio IT Platform: What is new with version 3.9 updates
August 13, 2021
Learn about the latest DRAGEN features and enhancements with the v3.9 release. Significant highlights include the availability of DRAGEN on Microsoft Azure, RNA variant calling, Homologous Recombination Deficiency (HRD) for WGS data, graph genome accuracy improvements (most notably in the MHC region), and expanded capabilities in our single-cell pipeline. Additional updates in this release include streamlined CNV calling and methylation pipelines, gene fusion detection in repetitive regions, and increased ease of use of DRAGEN ORA (FASTQ compression). View upcoming Support Webinars
support.illumina.com/training.html Subscribe to the Illumina video channel
youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos
youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM